Riccardo Morandi
Overview
Explore the profile of Riccardo Morandi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
49
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gatta E, Pirola I, Gotti A, Fredi M, Bellini P, Dondi F, et al.
J Clin Endocrinol Metab
. 2025 Mar;
PMID: 40036965
Context: Graves' disease can occur as an isolated condition or as part of an autoimmune polyglandular syndrome; there are no data regarding the differences in phenotype between these two forms....
2.
Morandi R, Guarneri C, Nardin M, Mitola S, Vettoretto N, Zanni G, et al.
Langenbecks Arch Surg
. 2024 Nov;
409(1):350.
PMID: 39551899
Purposes: Evaluate the changes in quality of life (QoL) in patients affected by tertiary hyperparathyroidism (THPT) after surgical treatment using the Parathyroidectomy Assessment of Symptoms (PAS) and Short Form-36 (SF-36)...
3.
Casella C, Guarneri C, Campanile M, Adhoute X, Gelera P, Morandi R
Front Endocrinol (Lausanne)
. 2023 Nov;
14:1226917.
PMID: 38027172
Background: Tertiary hyperparathyroidism (3HPT) is defined as a condition of excessive autonomous excretion of intact parathyroid hormone (iPTH) with persistent hypercalcemia (>10.5 mg/dL) that lasts for more than 12 months...
4.
Galani A, Morandi R, Dimko M, Molfino S, Baronchelli C, Lai S, et al.
World J Surg Oncol
. 2021 Jan;
19(1):19.
PMID: 33472651
Background: Primary hyperparathyroidism is an endocrine pathology that affects calcium metabolism. Patients with primary hyperparathyroidism have high concentrations of serum calcium or high concentrations of parathyroid hormone, or incorrect parathyroid...
5.
Casella C, Morandi R, Verrengia A, Galani A, Molfino S, Cuka D, et al.
Endocr Metab Immune Disord Drug Targets
. 2020 Dec;
21(11):2028-2034.
PMID: 33380308
Background: The existence of a link between Graves' Disease (GD) and Thyroid Cancer (TC) has long been investigated, however a clear pathogenic correlation is yet to be found. Objective: We...
6.
Lodi M, Bigi E, Palazzi G, Vecchi L, Morandi R, Setti M, et al.
Hemoglobin
. 2017 Dec;
41(4-6):230-233.
PMID: 29233055
The implementation of screening programs for early detection of patients with sickle cell disease has become necessary in Italy as a result of the high rate of migration from areas...
7.
Fontana F, Ballestri M, Makomi C, Morandi R, Cappelli G
Clin Hemorheol Microcirc
. 2016 Jun;
65(2):175-183.
PMID: 27340762
Dialysis patients present a cardiovascular risk substantially higher than general population, due to both traditional and non-traditional risk factors. Hemorheologic alterations have been extensively described in hemodialysis patients (HD), while...
8.
Toni S, Morandi R, Busacchi M, Tardini L, Merlini L, Battistini N, et al.
Front Aging Neurosci
. 2014 Dec;
6:315.
PMID: 25477818
Collagen VI mutations lead to disabling myopathies like Bethlem myopathy (BM) and Ullrich congenital muscular dystrophy (UCMD). We have investigated the nutritional and metabolic status of one UCMD and seven...